Regentis Biomaterials Ltd.
RGNTAMEX
Healthcare
Medical - Instruments & Supplies
Herzliya, ILregentis.co.il
$3.11
+0.11(3.67%)
52W $2.92 – $7.70
AI-generated
Regentis Biomaterials Ltd., a regenerative medicine company, develops tissue repair solutions that restore the health and enhance quality of life of patients.
$12MMkt Cap
—Rev TTM
—NI TTM
Fundamentals
How The Business Makes Money
Regentis Biomaterials Ltd., a regenerative medicine company, develops tissue repair solutions that restore the health and enhance quality of life of patients. Its lead product candidate is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries and articular knee cartilage. The company focuses on developing orthopedic treatments using its Gelrin platform that is based on degradable hydrogel implants to regenerate damaged or diseased tissue. Regentis Biomaterials Ltd. was incorporated in 2004 and is based in Herzliya, Israel.
Industry Medical - Instruments & Supplies
Company Profile
CIK0001912966
ISINIL0012190968
CUSIP001219096
Phone972 9 960 1917
Address60 Medinat Hayehudim Street, Herzliya, 4676652, IL
SEC EDGAR